Amgen

Amgen announces data from romosozumab, Prolia studies
The Fly on the Wall
Fri, 10/4/13 - 11:17 am
Amgen
romosozumab
Prolia
UCB
bone mineral density
New class of psoriasis drugs being developed
Bloomberg
Fri, 10/4/13 - 10:14 am
psoriasis
Novartis
AstraZeneca
Amgen
Eli Lilly
Enbrel
secukinumab
brodalumab
IL-17 blockers
Top Biotechs Set to Win in the War on Cancer
Yahoo/Wall St 24-7
Thu, 10/3/13 - 11:57 am
biotech
Biomarin
Immunogen
Ariad Pharmaceuticals
Amgen
Celgene
Gilead Sciences
Top 15 Drug Launch Superstars
Fierce Pharma
Thu, 10/3/13 - 10:35 am
drug launches
Eylea
Regeneron
Bayer
Tecfidera
Biogen Idec
Kalydeco
Vertex Pharmaceuticals
Kadcyla
Roche
Genentech
Victoza
Novo Nordisk
Gilenya
Novartis
Zytiga
JNJ
Yervoy
Bristol-Myers Squibb
Stribild
Gilead Sciences Xtandi
Medivation
Astellas
Afinitor
Amgen
Prolia
Stelara
Kyprolis
Xarelto
ONYX Pharmaceuticals
Amgen Successfully Completes Onyx Pharmaceuticals Tender Offer
Yahoo
Tue, 10/1/13 - 08:50 am
Amgen
ONYX Pharmaceuticals
M&A
Amgen's 10 Billion Dollar Molecule
Seeking Alpha
Mon, 09/30/13 - 10:44 am
Amgen
Takeda
ONYX Pharmaceuticals
Kyprolis
China Biotech In Review: Amgen Partners With ShanghaiTech On China R&D Center
Seeking Alpha
Sun, 09/29/13 - 01:29 pm
Mindray
JHL Biotech
Amgen
Sinochem Jiangsu Pharma
Boehringer Ingelheim
3 Signs We Could Be Entering a Biotech Bubble
Motley Fool
Sat, 09/28/13 - 01:09 pm
biotech
Perrigo
Bristol-Myers Squibb
Elan
Clovis Oncology
IPOs
Stemline
Amgen
Biogen Idec
ONYX Pharmaceuticals
Phase 3 Trial Comparing Vectibix® (Panitumumab) to Erbitux® (Cetuximab) Meets Primary Endpoint Of Non-Inferiority Of Overall Survival
Yahoo/PR NewsWire
Sat, 09/28/13 - 11:56 am
Vectibix
colorectal cancer
Amgen
Amgen Plans R&D Center in China
GenEngNews
Fri, 09/27/13 - 08:32 am
Amgen
R&D
China
Ex-CEO of Amgen, Kevin Sharer, on Leadership
Harvard Business Review
Thu, 09/26/13 - 08:21 am
Amgen
Leadership
Pharma CEOs
Kevin Sharer
Insiders Are Selling Biogen Idec
Seeking Alpha
Tue, 09/24/13 - 05:57 pm
Biogen Idec
AbbVie
Amgen
Bristol-Myers Squibb
JNJ
Merck
Pfizer
Cephalon
Acceleron: A Small Biotech Preparing To Supply Big Markets
Seeking Alpha
Mon, 09/23/13 - 09:47 am
Acceleron
Amgen
Celgene
IPOs
With $29B in deals so far, 2013 shaping up as big M&A year
Fierce Pharma
Fri, 09/20/13 - 10:23 am
M&A
Valeant Pharmaceuticals
Bausch & Lomb
ONYX Pharmaceuticals
Amgen
[video]Biotech IPOs With Big Partners
TheStreet.com
Thu, 09/19/13 - 03:13 am
biotech
IPOs
Celgene
Amgen
Bind Therapeutics
Acceleron
Fate Therapeutics
Top 10 rheumatoid arthritis drugs 2013
Fierce Pharma
Wed, 09/18/13 - 10:27 am
rheumatoid arthritis
Humira
AbbVie
Enbrel
Amgen
Remicade
Janssen
Celebrex
Pfizer
Bristol-Myers Squibb
Orencia
Cimza
UCB
Simponi
JNJ
Arthrotec
Vimovo
AstraZeneca
Kineret
Fallout From This Heart-Drug Failure
Motley Fool
Sat, 09/14/13 - 10:49 am
Amgen
Omecamtiv Mecarbil
heart failure
Cytokinetics
Top Biotech Stock Picks for Q4 2013: An Interview with the Senior Analyst at Oppenheimer & Company
Yahoo/Wall St Transcript
Sat, 09/14/13 - 10:38 am
Amgen
Celgene
ONYX Pharmaceuticals
Keryx
Pluristem Therapeutics
NPS Pharmaceuticals
Can This Biotech Star Deliver for Dividend Investors?
Motley Fool
Sat, 09/14/13 - 10:35 am
Amgen
Cheers and Jeers for Amgen's Pipeline
Motley Fool
Thu, 09/12/13 - 08:13 am
Amgen
AMG-145
Omecamtiv Mecarbil

Pages